as on October 30, 2025 at 1:29 am IST
Day's High
9.26%
Upside
52 Week's Low
52 Week's High
69.74%
Downside
327.76%
Upside
Check Plus Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$59.8M
EPS (TTM)
-0.24
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.63
Industry PE ratio
0PEG Ratio
0EBITDA
-12.2M
Revenue (TTM)
5.3M
Profit Margin
0.00%
Return On Equity TTM
-522.50%
Track how Plus Therapeutics Inc P/E has moved over time to understand its valuation trends.
Plus Therapeutics Inc in the last 5 years
Lowest (-24.58x)
March 31, 2021
Industry (0.00x)
October 29, 2025
Today (-0.63x)
October 29, 2025
Highest (-0.37x)
June 30, 2025
Today’s Price to Earnings Ratio: -0.63x
Compare market cap, revenue, PE, and other key metrics of Plus Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $59.8M | -98.27% | -0.63 | 0.00% | |
| BUY | $62.7B | 285.91% | -505.15 | -12.96% | |
| NA | $36.5B | NA | NA | -3.89% | |
| BUY | $108.0B | 104.04% | 29.95 | 31.86% | |
| BUY | $62.0B | 17.76% | 14.75 | 31.37% |
The Plus Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Plus Therapeutics Inc investment value today
Current value as on today
₹45,061
Returns
Returns from Plus Therapeutics Inc Stock
Dollar Returns*
₹5,061 (+5.06%)
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Plus Therapeutics Inc. Average target price of $8
Get share price movements and forecasts by analysts on Plus Therapeutics Inc.
What analysts predicted
93.25%UPSIDE
Target Price
$8
Current Price
$0.54
Analyzed by
10 Analysts
Target
$8.00
Plus Therapeutics Inc target price $8, a slight upside of 93.25% compared to current price of $0.54. According to 10 analysts rating.
Investment in Plus Therapeutics Inc Shares on INDmoney has grown by 66.24% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:66.24% versus previous 30 day period
Search interest for Plus Therapeutics Inc Stock has increased by 129% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:129% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 1.05M → 1.39M (in $), with an average increase of 23.8% per quarter
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -17.40M → 5.15M (in $), with an average increase of 437.8% per quarter
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 132.7% return, outperforming this stock by 224.7%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.2% return, outperforming this stock by 123.9%
Price Dip
![]()
In the last 1 month, PSTV stock has moved down by -29.6%
| Organisation | Plus Therapeutics Inc |
| Headquarters | 2710 Reed Road, Houston, TX, United States, 77051 |
| Industry | Health Technology |
| CEO | Dr. Marc H. Hedrick M.B.A., M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Marc H. Hedrick M.B.A., M.D. | President, CEO & Director |
Mr. Andrew J. Sims CPA | VP of Finance & CFO |
Mr. Russ Havranek M.B.A., M.S. | Executive Vice President of Commercial and Corporate Strategy |
Dr. Michael Stanley Rosol Ph.D. | Chief Development Officer |
Ms. Desiree Smith | Corporate Controller |
Mr. Russell W. Bradley | President & GM of CNSide Diagnostics |
Plus Therapeutics Inc share price today is $0.54 as on at the close of the market. Plus Therapeutics Inc share today touched a day high of $0.59 and a low of $0.54.
Plus Therapeutics Inc share touched a 52 week high of $2.31 on and a 52 week low of $0.16 on . Plus Therapeutics Inc stock price today i.e. is closed at $0.54,which is 76.62% down from its 52 week high and 230.48% up from its 52 week low.
Plus Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Plus Therapeutics Inc (PSTV) shares with as little as ₹88.178 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.78 in Plus Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Plus Therapeutics Inc share’s latest price of $0.54 as on October 30, 2025 at 1:29 am IST, you will get 18.5185 shares of Plus Therapeutics Inc. Learn more about
fractional shares .
Plus Therapeutics Inc stock has given -98.27% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?